(Q39757763)

14 September 2017

Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer (English)

1 reference

14 September 2017

cervix uterine cancer

1 reference

10

Tadashi Kimura

1 reference

14 September 2017

1

Seiji Mabuchi

1 reference

14 September 2017

6

Eiichi Morii

1 reference

14 September 2017

4

Yasuo Yoshioka

1 reference

14 September 2017

2

Yuri Matsumoto

1 reference

14 September 2017

3

Fumiaki Isohashi

1 reference

14 September 2017

Hiroshi Ohashi

5

1 reference

14 September 2017

Toshimitsu Hamasaki

series ordinal

7

1 reference

14 September 2017

Katsuyuki Aozasa

series ordinal

8

1 reference

14 September 2017

David G Mutch

series ordinal

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

22 April 2011

1 reference

14 September 2017

1 reference

14 September 2017

122

1 reference

14 September 2017

1

1 reference

14 September 2017

25-32

1 reference

14 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Management of early and locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Management of metastatic cervical cancer: review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

An update on the etiology and diagnostic evaluation of a leukemoid reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Granulocyte colony-stimulating factor-producing small-cell carcinoma of the uterine cervix: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

A case of uterine cervical cancer presenting with granulocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

The first 2 cases of granulocyte colony-stimulating factor producing adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Leukocytosis as an initial sign of aggressive growth of granulocyte colony-stimulating factor-producing cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

A leukemoid reaction in a patient with a dedifferentiated liposarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Gingival cancer suspected of producing granulocyte colony-stimulating factor: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Anaplastic thyroid carcinoma associated with granulocyte colony-stimulating factor: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

A case of granulocyte-colony stimulating factor producing gallbladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Granulocyte-colony stimulating factor producing rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.037

10.1016/J.YGYNO.2011.03.037

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference